The sensitivity and specificity of the novel evaluation with KRAS mutation, BMP3 and NDRG4 methylation, and FOB for CRC diagnosis were 97.96% and 88.71%, respectively. The gene discussed is KRAS; the disease is colorectal carcinoma.